ConforMIS News

Company News

  • Tuesday, 7/11/17

    ConforMIS Names Dan Krupp Senior Vice President U.S. Sales

    Krupp

    BILLERICA, Mass., July 11, 2017 (GLOBE NEWSWIRE) — ConforMIS, Inc. (NASDAQ:CFMS), a medical technology company that offers joint replacement implants customized to fit each patient’s unique anatomy, today announced that Dan Krupp has joined the Company as its Senior Vice President of U.S. Sales, effective July 3, 2017. A photo accompanying this announcement is available…

    Read more »
  • Tuesday, 6/20/17

    ConforMIS Announces FDA 510(k) Clearance for iTotal Hip System

    Segmentation of scout CT-hip3

    New hip replacement implant system builds on ConforMIS’s customized knee replacement technology and positions Company to expand in global orthopedics market Billerica, Mass. – June 20, 2017 (GLOBE NEWSWIRE) – ConforMIS, Inc. (NASDAQ:CFMS), a medical technology company that offers knee replacement implants customized to fit each patient’s unique anatomy, today announced it has received FDA 510(k) clearance…

    Read more »
  • Friday, 3/31/17

    ConforMIS, Inc. Announces Election of Philip W. Johnston to its Board of Directors

    Press-Release-Image-C-300x180

    Bedford, Mass. – March 31, 2017 (GLOBE NEWSWIRE) – ConforMIS, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are customized to fit each patient’s unique anatomy, announced today that its Board of Directors elected Philip W. Johnston to the Board commencing as of…

    Read more »
  • Monday, 10/17/16

    ConforMIS Announces Publication of Clinical Study Demonstrating iTotal CR Customized Implants Better Approximate Normal Knee Motion When Compared to a Leading Off-the-Shelf Total Knee Implant

    Press-Release-Image-C-300x180

    Head-to-head study published in The Journal of Arthroplasty also demonstrated improved mid-flexion stability Bedford, Mass. – October 17, 2016 – ConforMIS, Inc. (NASDAQ:CFMS), a medical technology company that develops, manufactures and sells joint replacement implants that are customized to fit each patient’s unique anatomy, today announced that The Journal of Arthroplasty has accepted for printed publication, and published…

    Read more »
  • Tuesday, 10/4/16

    ConforMIS Announces Sale of Over 50,000 Customized Knee Implants

    Press-Release-Image-C-300x180

    To Commemorate Milestone, ConforMIS to Host Inaugural Patient Ambassador Summit Bedford, Mass. – October 4, 2016 – ConforMIS, Inc. (NASDAQ:CFMS), a medical technology company that develops, manufactures and sells joint replacement implants that are customized to fit each patient’s unique anatomy, today announced a significant milestone. ConforMIS has sold more than 50,000 implants, each individually sized and shaped…

    Read more »
  • Monday, 8/15/16

    Clinical Studies Demonstrate ConforMIS iTotal CR Customized Knee Implants Provide Superior Outcomes and Potential for Economic Savings

    Press-Release-Image-C-300x180

    New clinical study demonstrates potential for ConforMIS iTotal CR customized knee implants to contribute cost savings across episode of care Bedford, Mass. – August 15, 2016 – ConforMIS, Inc. (NASDAQ:CFMS), a medical technology company that develops, manufactures and sells joint replacement implants that are customized to fit each patient’s unique anatomy, announced today the results from two clinical…

    Read more »
  • Wednesday, 7/6/16

    Study Finds High Satisfaction Amongst Patients with ConforMIS Customized Total Knee Replacements

    iTotal-CR-502x301

    New data corroborates previous study that demonstrated higher satisfaction with iTotal CR than traditional, off-the-shelf implants Bedford, Mass. – July 6, 2016 – ConforMIS, Inc. (NASDAQ: CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are customized to fit each patient’s unique anatomy, announced today…

    Read more »
  • Tuesday, 6/21/16

    ConforMIS iTotal® PS Customized Knee Replacement Honored as 2016 Gold Stevie® Award Winner

    ConforMIS Stevie Award

    Accolade recognizes innovation in first-ever customized posterior-stabilized total knee replacement system Bedford, Mass. – June 21, 2016 – ConforMIS, Inc. (NASDAQ: CFMS), a medical technology company that offers joint replacement implants customized to fit each patient’s unique anatomy, today announced that their newest product to market, the iTotal® PS posterior-stabilized total knee replacement system, was named the winner…

    Read more »
  • Wednesday, 3/2/16

    ConforMIS Announces Full Commercial Launch of iTotal® PS, the Only Customized Posterior Stabilized Total Knee Replacement System

    iTotal_PS_posterior view_502x301

    iTotal PS nearly triples the available market for ConforMIS Bedford, Mass. – March 2, 2016 – ConforMIS, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are customized to fit each patient’s unique anatomy, today announced the full commercial launch of iTotal® PS, the…

    Read more »
  • Wednesday, 7/1/15

    ConforMIS CEO: Getting A Knee Up (Mad Money, CNBC)

    Philipp Lang ConforMIS CEO on CNBC Mad Money

    Click here to read the full show recap on TheStreet.com ConforMIS is not responsible for the contents or reliability of any third-party materials accessible on ConforMIS’s website, including embedded videos, audio recordings and images, or links to external websites or other third-party materials. The information contained in such third-party materials may not be accurate or…

    Read more »